Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KB2115 add-on to statin therapy in dyslipidemia (Phase II)
2007-004413-33Phase 2Completed
- Sponsor
- Karo Healthcare AB
- Start
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in hypercholesterolemia and primary hypercholesterolaemia comparing KB2115 + statin with Placebo + statin (2 arms). Primary endpoint: Absolute change in LDL cholesterol from baseline to 12 weeks. Started Sep 2007; status: completed.
02
Drugs
eprotirome
03
Conditions
hypercholesterolemiaprimary hypercholesterolaemia
Beyond the preview
Go deeper on 2007-004413-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004413-33.